MetLife stock: buy or sell

MET stock price: $50.86 -0.41% At close on Jan 22nd, 2021

Updated on:
Jan 25th, 2021

2

MetLife stock brief

  • After marking all-time highs last Tuesday, MetLife closed last Friday at $50.86 just moving a -0.41%
  • MetLife, Inc. engages in the insurance, annuities, employee benefits, and asset management businesses worldwide. It operates through five segments: U.

Should I buy MetLife stock?

All successful traders recommend adhering to a trading strategy and not make decisions based on subjective opinions, rumors or feelings. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best moment to buy them. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best

Is $MET stock a buy?

In the current situation of MetLife there is just one buy setup eligible:

Uptrend buy setup

MetLife stock continues to trend higher since in September 2020 and marked a gorgeous 46.32% gain. Price marked a pull back in this uptrend at $44.62 in mid-December, and since then it bounced off a 13.98%. Price just broke out above the entry point at $48.89, but it's still eligible. If price goes beyond $51.33, you should not chase the price and wait for another opportunity. If you decide to enter this trade, the suggested stop loss is at $44.00

Buy setupBuy pointStop lossRisk
Uptrend buy setup$48.89$44.0010.00%

Should I sell MetLife stock?

"To sell or not to sell", if you are holding MetLife shares?. Trading strategies allow us to avoid impulsive decisions based on our personal feelings or the buzz surrounding the market. We like very simple setups to guide us on when is the best time to sell our shares. Be aware that these setups are not intended for shorting $MET stock

A golden rule is that you should never mantain an investment that produces losses greater than those expected by the time of the buy. The moment to sell your stock must always be determined by the stop-loss (automatic or manual)

Is it time to sell MetLife stock?

In the current situation of MetLife there is not any eligible sell setup, so MetLife stock holders with operations in green can keep their positions

MetLife ratings

In the last month, 2 ratings were published for MetLife. General sentiment is bullish, with 2 out of 2 publishing optimistic forecasts

MetLife analysts' ratings - Last 30 days
Brokerage firmRating
Jan 6th, 2021
Piper Sandler NeutralBuy
Jan 15th, 2021
Morgan Stanley Buy

MetLife stock analysis

MetLife shares started an uptrend in September 2020, and grew a gorgeous 46.32%. During this uptrend, the price gave some entry points on the breakouts. Latest low was in mid-December, when price bounced at $44.62. MetLife broke out above $48.89 (its last top) on January 6. That breakout was a good entry point

$MET at All-time Highs

MetLife did it again, and marked all-time highs (ATH) last Tuesday at $52.38

SMAs overview

MET stock SMAs chart

Supports and resistances

The current resistances are:

  • R1: $51.27 (0.81% above)
  • The current supports are:

  • S1: $50.32 (-1.06% below)
  • S2: $49.30 (-3.07% below)
  • S3: $49.18 (-3.30% below)
  • Bollinger bands

    Since the price surpassed the upper band last Tuesday, the price has corrected downwards by 2.90%

    MET stock Bollinger Bands chart

    Relative strength index

    The RSI dropped below the overbought level of 70 last Wednesday after just crossing to the overbough zone for just one day (weak signal). The RSI value last Friday was 63.58

    MET stock RSI chart

    MetLife stock price history

    MetLife started trading on Apr 5th, 2000 at $8.31 per share1. Since then, MET stock surged by 512.03%, with an average of 25.60% per year. An investment of thousand dollars at that time would have a value of $6,120.34 nowadays.

    1: Adjusted price after possible price splits or reverse-splits

    MET stock price history chart

    Price target for MetLife stock

    Nobody knows how much a share will be priced tomorrow. Banks and financial organisations post their analysis forecasting how a stock will performance in the future.

    Along with buy or sell recommendations, financial institutions post their price estimates based on the stock price action and the company fundamental data. Most of these forecasts follow the publication of new financial information by the company, and many times. Again, these predictions are not direct recommendations for small traders and should not be followed blindly.

    The average price target for MetLife stock calculated from the table below is $54.50. That is a 7.16% than the current price ($50.86).

    MetLife stock price predictions
    Brokerage firmPrice target
    Jan 6th, 2021
    Piper Sandler $45.00$52.00
    Jan 15th, 2021
    Morgan Stanley $53.00$57.00

    Earnings and financials

    MetLife ($MET) hosted the investors call and posted the report last November. MetLife surpassed analysts estimates and posted of $1.95, that is a 21.12% better than expected compared to the predictions of $1.61. Despite this, reported sales of $16.5 billion were in line with consensus predictions.

    Same quarter one year ago, reported EPS was $1.27, so recently reported EPS means an increase of 53.54%. Sales dropped a -14.26% on an annualized basis in the , from $186.8B to $160.2B last quarter.

    MetLife ($MET) is releasing financial report on Wednesday next week. Wall Street expects of $1.52, compared to previous quarter that was $1.95.

    MetLife competitors

    MetLife is classified inside the Insurance - Life industry, where it has industry peers.

    MetLife biggest competitors are:

    MetLife competitors
    CompanyMarket capRatingBullish ratings1
    MetLife ($MET) $46.0B Buy 2
    Prudential Public (PUK) $51.0B Strong buy 1
    AEGON (AEG) $8.9B Neutral 0
    Assurant (AIZ) $8.3B Buy 1
    American Financial (AFG) $7.9B Neutral 0
    Voya Financial (VOYA) $7.6B Buy 1
    CNO Financial (CNO) $3.2B Buy 2
    Horace Mann Educators (HMN) $1.8B Neutral 0

    1 In the last 30 days.

    MetLife performance

    To better understand MetLife stock performance you must compare its gains with other related stocks in same sector or industry.. For MetLife, the benchmark is made against Prudential Public, AEGON, Assurant, American Financial, Voya Financial, CNO Financial and Horace Mann Educators.

    MET performance compared
    Company1m3m6m
    MetLife ($MET) 11.70% 31.40% 34.60%
    Prudential Public (PUK) 9.10% 37.10% 29.70%
    AEGON (AEG) 14.30% 50.00% 41.50%
    Assurant (AIZ) 2.90% 10.70% 26.50%
    American Financial (AFG) 0.60% 18.80% 38.70%
    Voya Financial (VOYA) 3.30% 13.70% 17.30%
    CNO Financial (CNO) 3.90% 28.20% 46.10%
    Horace Mann Educators (HMN) 4.00% 23.70% 12.90%

    Important note:
    The viewpoints given in this post are personal and should not be followed as recommendations for you to buy or sell shares. The author of this article does not know the individual situations of the reader, his or her own financial statements or his or her own best interests at any given time. All users should speak with their financial advisor before buying or selling any securities Opinions are provided for general educational reasons only

    MetLife summary

    Friday, January 22nd, 2021
    Open$50.36
    Close$50.86
    Day range$50.21 - $51.04
    Previous close$51.07
    Session gain-0.41%
    Average true range$1.64
    50d mov avg$47.40
    100d mov avg$42.76
    200d mov avg$39.14
    Earnings dateFebruary 3rd, 2021

    Frequently asked questions

    What is MetLife stock symbol?

    MetLife, Inc. is a public company trading in the US stock market with the MET symbol

    Is MetLife stock a buy or sell?

    MetLife received 2 ratings in the last 30 days: 2 bullish, 0 bearish and 0 neutral.

    Will MET go up?

    MetLife had different price forecasts posted by market analysts in the last 4 weeks forecasting the target price to $54.50. That is a 7.16% than the current price ($50.86).